Referred to the House Committee on Veterans' Affairs.
The bill adds a new section to title 38, United States Code, requiring the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription. It also amends 38 U.S.C. 1722A(a)(4) to remove the requirement for a copayment (by striking the remainder of the subsection and inserting a period).
Scope and funding: liberals and centrists see access and equity benefits; conservatives worry about costs and federal expansion.
Relative to its intended legislative type, this bill establishes a clear statutory mandate but provides minimal operational, fiscal, and accountability detail.
The bill adds a new section to title 38, United States Code, requiring the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription.
It also amends 38 U.S.C. 1722A(a)(4) to remove the requirement for a copayment (by striking the remainder of the subsection and inserting a period).
The bill does not specify funding, distribution mechanics, quantities, or additional programmatic details.
On content alone, this is a narrow, administratively simple change that addresses an uncontroversial public‑health objective for veterans. Those features historically improve prospects for enactment. Remaining barriers are mainly procedural (legislative scheduling, committee priorities) and the absence in the text of cost estimates or offset language that could invite scrutiny.
Relative to its intended legislative type, this bill establishes a clear statutory mandate but provides minimal operational, fiscal, and accountability detail.
Scope and funding: liberals and centrists see access and equity benefits; conservatives worry about costs and federal expansion.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope and funding: liberals and centrists see access and equity benefits; conservatives worry about costs and federal expansion.
A mainstream liberal would likely view this bill positively as a targeted, evidence-based public-health step to reduce overdose deaths among veterans.
They would see removing the prescription and copayment barriers as important for equitable access, especially for low-income, houseless, or otherwise marginalized veterans.
They would note the bill is limited in scope and straightforward, but press for accompanying measures (education, outreach, linkage to treatment).
A moderate would generally support the bill's aim to save lives and reduce barriers, but would seek clarity on costs, implementation, and oversight.
They would treat it as a narrowly focused, low-friction public-health intervention that probably has bipartisan appeal, provided the VA can implement it within existing budgets or with clear appropriations.
They would want metrics to ensure the program is effective and not an unfunded mandate.
A mainstream conservative would be mixed: sympathetic to a life-saving measure for veterans but concerned about expanding federal obligations, potential costs to taxpayers, and whether the policy could have unintended consequences.
They may prefer targeted, accountable implementation and want to ensure it does not become a gateway to broader federal mandates or recurring new programs without appropriations.
Some conservatives would accept naloxone distribution as pragmatic; others may view removing copays as an unnecessary subsidy.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a narrow, administratively simple change that addresses an uncontroversial public‑health objective for veterans. Those features historically improve prospects for enactment. Remaining barriers are mainly procedural (legislative scheduling, committee priorities) and the absence in the text of cost estimates or offset language that could invite scrutiny.
The bill has not accumulated any surfaced votes yet.
Scope and funding: liberals and centrists see access and equity benefits; conservatives worry about costs and federal expansion.
On content alone, this is a narrow, administratively simple change that addresses an uncontroversial public‑health objective for veterans.…
Relative to its intended legislative type, this bill establishes a clear statutory mandate but provides minimal operational, fiscal, and accountability detail.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.